AJP - Gastrointestinal and Liver Physiology, Vol 258, Issue 2 275-G281, Copyright © 1990 by American Physiological Society

ARTICLES

Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock

N. Aoki, G. Johnson 3rd and A. M. Lefer
Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.

We studied the effects of nitric oxide (NO) solution and acidified sodium nitrite (NaNO2), which produces NO, in splanchnic artery occlusion (SAO) shock in cats. NO is thought to be endothelium-derived relaxing factor (EDRF), a labile substance having several potentially valuable biological effects. Anesthetized cats subjected to total occlusion of the celiac, superior mesenteric, and inferior mesenteric arteries for 120 min, followed by reperfusion, usually died approximately 60 min after reperfusion. NO infusion significantly improved survival time in SAO-shock cats compared with those receiving vehicle (P less than 0.005). Administration of NO also attenuated the increase in plasma activities of the lysosomal hydrolase cathepsin D (P less than 0.05), total amino-nitrogen (P less than 0.001), and of the cardiotoxic peptide, myocardial depressant factor (MDF) (P less than 0.001). SAO-shock cats treated with NaNO2 at pH 2.0 also exhibited lower plasma cathepsin D (P less than 0.001), amino-nitrogen (P less than 0.05), and MDF activities (P less than 0.01), and survival time was also significantly improved (P less than 0.02). The same dose of NaNO2 infused at pH 7.4 failed to exert any significant protective effect. These results indicate that NO exerts beneficial effects in SAO shock in cats and suggest that exogenously administered NO may be a potentially useful therapeutic agent in splanchnic ischemic shock, probably via a cytoprotective rather than a vasodilator effect.

This article has been cited by other articles:

				R. SCALIA, K. M. COYLE, B. J. LEVINE, G. BOOTH, and A. M. LEFER C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction FASEB J, November 1, 2000; 14(14): 2357 - 2364. [Abstract] [Full Text]

				S. Sato, A. Suzuki, Y. Nakajima, T. Iwamoto, H. Bito, and M. Miyabe S-nitroso-N-acetylpenicillamine (SNAP) During Hemorrhagic Shock Improves Mortality as a Result of Recovery From Vascular Hyporeactivity Anesth. Analg., February 1, 2000; 90(2): 362 - 362. [Abstract] [Full Text] [PDF]

				P. Kubes, D. Payne, M. B. Grisham, D. Jourd-Heuil, and A. Fox-Robichaud Inhaled NO impacts vascular but not extravascular compartments in postischemic peripheral organs Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H676 - H682. [Abstract] [Full Text] [PDF]

				R. SCALIA, G. BOOTH, and D. J. LEFER Vascular endothelial growth factor attenuates leukocyte–endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide FASEB J, June 1, 1999; 13(9): 1039 - 1046. [Abstract] [Full Text]

				A. M. Lefer and D. J. Lefer II. Nitric oxide protects in intestinal inflammation Am J Physiol Gastrointest Liver Physiol, March 1, 1999; 276(3): G572 - G575. [Abstract] [Full Text] [PDF]

				R. Hayward and A. M. Lefer Time course of endothelial-neutrophil interaction in splanchnic artery ischemia-reperfusion Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2080 - H2086. [Abstract] [Full Text] [PDF]

				J. W. Horton, J. White, D. Maass, and B. Sanders Arginine in burn injury improves cardiac performance and prevents bacterial translocation J Appl Physiol, February 1, 1998; 84(2): 695 - 702. [Abstract] [Full Text] [PDF]

				R. Scalia, J. Gefen, N. A. Petasis, C. N. Serhan, and A. M. Lefer Lipoxin A4 stable analogs inhibit leukocyte rolling and adherence in the rat mesenteric microvasculature: Role of P-selectin PNAS, September 2, 1997; 94(18): 9967 - 9972. [Abstract] [Full Text] [PDF]

				T. W. Gauthier, R. Scalia, T. Murohara, J.-p. Guo, and A. M. Lefer Nitric Oxide Protects Against Leukocyte-Endothelium Interactions in the Early Stages of Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1652 - 1659. [Abstract] [Full Text]